ZEB2 and breast carcinoma: For instance, UBD shows elevated expression levels in breast cancer, and its down-regulation has been found to inhibit epithelial–mesenchymal transition (EMT) and the metastatic behavior of breast cancer cells, possibly through the stabilization of the ZEB2 protein [24].